This suggests that GLP-1R agonism attenuates T2DM-related increases in myocardial oxidative stress and cardiac myocyte apoptosis, respectively, key mediators of diabetic cardiomyopathy, though diastolic function was not assessed in this particular study. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.